Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301

NCT00149929 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

246

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplant

Interventions

DRUG: Mycophenolate sodium (enteric coated)

Sponsor

Novartis